The Basque biotechnology company, Progenika Biopharma, devoted to research and development in personalized medicine, have presented a DNA biochip, known as BLOODchip, which greatly eliminates the risk of adverse reactions due to incompatibility in blood groups between donor and receptor in blood transfusions.
People with diabetes are risking their health by not discussing their use of complementary and alternative therapies with the health professionals managing their conventional treatment.
Preimplantation genetic screening did not increase but instead significantly reduced the rates of ongoing pregnancies and live births after IVF in women of advanced maternal age.
Patients seeking cosmetic rhinoplasty (?nose jobs?) often exhibited personality abnormalities, including obsessiveness, hypochondriasis, and making false statements that make them look better compared with others (?good faking?), according to a new study published in the July 2007 issue of Otolaryngology ? Head and Neck Surgery.
An operation once popular for the treatment of ulcers may prove to be an overlooked weight-loss solution for the newly obese. The surgery, which removes part of the vagus nerve in the esophagus, resulted in
Two research studies published today in The New England Journal of Medicine found taking SSRIs (selective serotonin reuptake inhibitors), anti-depression drugs, during pregnancy did not significantly increase the overall risk for most birth defects. However, each study found that taking SSRIs during pregnancy was associated with a small increase in the risk of certain rare birth defects ? but they were different birth defects.
Researchers at the University of Alberta have identified a “central command system” for pulmonary hypertension, a disease that currently has no cure and kills thousands each year.
Current PET-CT scanners with standard commercial software designed to provide images of the heart are falsely indicating coronary artery disease in as many as 40 percent of patients, according to a study published today on the cover page of the Journal of Nuclear Medicine.
During vigorous exercise, heart muscle cells take a beating. In fact, some of those cells rupture, and if not for a repair process capable of resealing cell membranes, those cells would die and cause heart damage (cardiomyopathy).
Researchers from the Stem Cell Transplant Program and the Amyloid Treatment and Research Program at Boston University Medical Center (BUMC) have found that tandem cycles of high-dose chemotherapy and blood stem cell transplantation can help treat patients with immunoglobulin-light chain (AL) Amyloidosis who did not respond to initial treatment with this method.